Evolent Health Total Liabilities 2014-2025 | EVH
Evolent Health total liabilities from 2014 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
| Evolent Health Annual Total Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $1,353 |
| 2023 | $1,434 |
| 2022 | $958 |
| 2021 | $726 |
| 2020 | $752 |
| 2019 | $569 |
| 2018 | $533 |
| 2017 | $266 |
| 2016 | $288 |
| 2015 | $81 |
| 2014 | $39 |
| 2013 | $33 |
| Evolent Health Quarterly Total Liabilities (Millions of US $) |
|
|---|---|
| 2025-03-31 | $1,525 |
| 2024-12-31 | $1,353 |
| 2024-09-30 | $1,276 |
| 2024-06-30 | $1,237 |
| 2024-03-31 | $1,414 |
| 2023-12-31 | $1,434 |
| 2023-09-30 | $1,398 |
| 2023-06-30 | $1,381 |
| 2023-03-31 | $1,297 |
| 2022-12-31 | $958 |
| 2022-09-30 | $903 |
| 2022-06-30 | $691 |
| 2022-03-31 | $728 |
| 2021-12-31 | $726 |
| 2021-09-30 | $646 |
| 2021-06-30 | $679 |
| 2021-03-31 | $688 |
| 2020-12-31 | $752 |
| 2020-09-30 | $737 |
| 2020-06-30 | $623 |
| 2020-03-31 | $604 |
| 2019-12-31 | $569 |
| 2019-09-30 | $590 |
| 2019-06-30 | $506 |
| 2019-03-31 | $479 |
| 2018-12-31 | $533 |
| 2018-09-30 | $274 |
| 2018-06-30 | $270 |
| 2018-03-31 | $251 |
| 2017-12-31 | $266 |
| 2017-09-30 | $243 |
| 2017-06-30 | $244 |
| 2017-03-31 | $258 |
| 2016-12-31 | $288 |
| 2016-09-30 | $91 |
| 2016-06-30 | $85 |
| 2016-03-31 | $81 |
| 2015-12-31 | $81 |
| 2015-09-30 | $120 |
| 2015-06-30 | $91 |
| 2015-03-31 | $59 |
| 2014-12-31 | $39 |
| 2014-09-30 | $0 |
| 2014-06-30 | $0 |
| 2014-03-31 | $0 |
| 2013-12-31 | $33 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.105B | $2.555B |
| Evolent Health, Inc. is involved in the healthcare delivery and payment markets. The company provides technology-enabled services platform for providers to transition their organization in value-based payment models. Evolent Health, Inc. is based in Arlington, Virginia. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.937B | 59.72 |
| Hims & Hers Health (HIMS) | United States | $13.490B | 140.16 |
| Doximity (DOCS) | United States | $11.213B | 51.91 |
| Tempus AI (TEM) | United States | $10.091B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.366B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.822B | 59.72 |
| Hinge Health (HNGE) | United States | $3.402B | 0.00 |
| Privia Health (PRVA) | United States | $2.375B | 162.33 |
| 10x Genomics (TXG) | United States | $1.724B | 0.00 |
| Phreesia (PHR) | United States | $1.614B | 0.00 |
| Enovis (ENOV) | United States | $1.561B | 8.70 |
| Schrodinger (SDGR) | United States | $1.553B | 0.00 |
| Azenta (AZTA) | United States | $1.553B | 72.17 |
| Clover Health Investments (CLOV) | United States | $1.471B | 0.00 |
| Omnicell (OMCL) | United States | $1.387B | 24.48 |
| Claritev (CTEV) | United States | $0.635B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.535B | 0.00 |
| Standard BioTools (LAB) | United States | $0.528B | 0.00 |
| Veradigm (MDRX) | United States | $0.503B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.453B | 0.00 |
| Talkspace (TALK) | United States | $0.420B | 125.50 |
| TruBridge (TBRG) | United States | $0.328B | 728.00 |
| Outset Medical (OM) | United States | $0.311B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.273B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.255B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.218B | 0.00 |
| CapsoVision (CV) | United States | $0.210B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.182B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.161B | 0.00 |
| American Well (AMWL) | United States | $0.129B | 0.00 |
| Pulmonx (LUNG) | United States | $0.124B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.122B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.117B | 0.00 |
| CareCloud (CCLD) | United States | $0.100B | 3.82 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.079B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.078B | 0.00 |
| 111 (YI) | China | $0.060B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.042B | 0.00 |
| HeartBeam (BEAT) | United States | $0.041B | 0.00 |
| Zhongchao (ZCMD) | China | $0.025B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.022B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.021B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| PROFUSA (PFSA) | United States | $0.005B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |